• Explore /
  • Poster
  • / ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68).

ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68).

Abstract Poster

Authors

null

Thomas J. Herzog

College of Medicine, University of Cincinnati, Cincinnati, OH

Thomas J. Herzog , John L. Hays , Joyce N. Barlin , Joseph Buscema , Noelle Gillette Cloven , Lynn R. Kong , Nidhi Kumar Tyagi , Grainger Lanneau , Beverly J Long , Robert L. Marsh , Shelly Marie Seward , David Starks , Stephen Welch , Kathleen N. Moore , Panagiotis A. Konstantinopoulos , Lucy Gilbert , Bradley J. Monk , David M. O'Malley , Robert L. Coleman , Jalid Sehouli

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT05092360

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS5612)

DOI

10.1200/JCO.2023.41.16_suppl.TPS5612

Abstract #

TPS5612

Poster Bd #

307a

Abstract Disclosures

Similar Posters

First Author: Thomas J. Herzog

First Author: Sarina Anne Piha-Paul

First Author: Kathleen N. Moore

First Author: Kathleen N. Moore